http://rdf.ncbi.nlm.nih.gov/pubchem/patent/EP-0545212-A1
Outgoing Links
| Predicate | Object |
|---|---|
| assignee | http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_f3cd12257804e2d7f96cff826faa97e3 |
| classificationCPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-57 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-56 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-565 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K47-10 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K9-0019 |
| classificationIPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-57 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K9-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K47-10 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-56 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-565 |
| filingDate | 1992-11-24-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor | http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_d47184f97f183ba02303bcb314ea028f http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_ca3e8efc2dc6d6dd8a8363b1f3b1c945 |
| publicationDate | 1993-06-09-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber | EP-0545212-A1 |
| titleOfInvention | Use of glucocorticoid monoesters, especially dexamethasone-in-sulfobenzoate, for the preparation of a parenterally applicable medicament for the treatment of diseases for which glucocorticoids are indicated |
| abstract | Use of monoesters from glucocorticoids on the one hand and physiologically tolerable organic acids bearing at least one hydrophilic group on the other hand for the production of parenterally administrable agents with prolonged release, in which they are in dissolved form, for diseases which can be treated with glucocorticoids in human medicine, the acid component as a hydrophilic group Contains hydroxyl and / or the sulfonic acid residue.n n n The invention further relates to a method for the treatment of diseases for which the use of glucocorticoids is indicated, in which an agent of the aforementioned type is administered parenterally to the patient. |
| priorityDate | 1991-11-28-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type | http://data.epo.org/linked-data/def/patent/Publication |
Incoming Links
Total number of triples: 101.